Pfizer Profit Beats Analyst Estimates on Lower Costs

Pfizer Profit Beats Analyst Estimates on Lower Costs

JB Reed/Bloomberg

Pfizer Inc.'s cholesterol drug Lipitor’s patent ended in Canada and Spain and the medicine will lose protection in the U.S. in November.